P95 Acquires 4Clinics to Expand Global CRO Services

P95 BV (Ampersand-backed) Merges South Africa CRO OnQ Research into P95

October 16, 2023

Healthcare Services

P95 BV, a vaccine-focused CRO and portfolio company of Ampersand Capital Partners, has signed an agreement to merge South Africa-based contract research organization OnQ Research into P95. The deal, structured as an add-on to P95, expands P95's presence across Africa and enhances its vaccine and infectious-disease clinical research and real-world evidence capabilities.

P95 BV Acquires Assign DMB

September 5, 2024

Healthcare Services

P95 BV, a Belgium-based epidemiology and clinical solutions provider backed by Ampersand Capital Partners, has acquired Assign DMB, an Innsbruck, Austria-based clinical research organisation specializing in clinical data management and biostatistics. The deal expands P95's capabilities and capacity to run clinical and non-interventional studies—particularly in vaccines and infectious diseases—and broadens its presence in Europe and globally.

Julius Clinical (Ampersand-backed) Merges with Peachtree BioResearch Solutions

May 14, 2025

Healthcare Services

Julius Clinical, a Netherlands-based CRO supported by Ampersand Capital Partners, has merged with Peachtree BioResearch Solutions, a specialized CNS CRO based in Georgia, USA. The merger creates a larger, fully integrated global CRO with expanded CNS capabilities and enhanced access across Europe and North America.

Velocity Clinical Research Acquires MedPharmics

September 7, 2022

Healthcare Services

Velocity Clinical Research, a portfolio company of GHO Capital, has acquired MedPharmics, a U.S.-based multi-site clinical research organization. The add-on expands Velocity's network by eight sites (bringing it to 40 locations), adds just over 100 employees, and improves access to diverse patient populations including African American and Native American communities.

WEP Clinical Acquires Netherlands-Based CRO Siron Clinical

January 14, 2026

Healthcare Services

WEP Clinical, a global contract research organization, has acquired Netherlands-based Siron Clinical to expand its European footprint and enhance Phase I–IV trial delivery capabilities. Siron — with offices in Belgium and Germany and a track record in orphan, pediatric, and medical device trials — will be integrated into WEP’s Clinical Trials division to broaden operational capacity and geographic reach.

Pinnacle Clinical Research Adds Five Sites to Network (KMC, CRCNJ, Bellaire, Palmetto, DRI)

June 18, 2024

Healthcare Services

Pinnacle Clinical Research, a portfolio company of LongueVue Capital, has acquired or partnered with five clinical research sites — Kerwin Medical Center, The Cognitive and Research Center of New Jersey, Bellaire Clinical Research, Palmetto Clinical Research – Low Country, and Dallas Research Institute — expanding Pinnacle’s network to 12 U.S. sites. The transactions broaden Pinnacle’s geographic footprint and add CNS/Alzheimer’s and metabolic disease capabilities, strengthening the platform’s ability to serve sponsors and underrepresented patient populations.